切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - cysteine protease - Inward Rectifier Potassium (Kir) Channels - GABA receptors - PARP

17件产品中的 1-10

页面
每页
清除全部
  1. Rucaparib (free base)
    A8893 Rucaparib (free base)
    中文名: 瑞卡帕布
    Target: PARP
    Summary: PARP抑制剂
      ≥16.15 mg/mL
      insoluble in H2O
  2. Oxiracetam
    B4748 Oxiracetam
    中文名: 奥拉西坦
    Target: GABA receptors
    Summary: γ-氨基丁酸(GABA)的环状衍生物
      ≥27.4 mg/mL
      ≥42.3 mg/mL
  3. Z-FA-FMK
    A8170 Z-FA-FMK
    Target: cysteine protease
    Summary: 半胱氨酸蛋白酶抑制剂
      ≥13.45 mg/mL
      insoluble in H2O
  4. Nateglinide
    B2198 Nateglinide
    中文名: 那格列奈
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素促分泌剂
      ≥16.4 mg/mL
      insoluble in H2O
  5. Gliclazide
    B2195 Gliclazide
    中文名: 格列齐特
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥15.6 mg/mL
      insoluble in H2O
  6. Mitiglinide Calcium
    B2193 Mitiglinide Calcium
    中文名: 米格列奈钙
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥33.45 mg/mL
      insoluble in H2O
  7. Glibenclamide
    B1296 Glibenclamide
    中文名: 格列本脲
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素生产调节剂
      ≥49.4 mg/mL
      insoluble in H2O
  8. ME0328
    A8808 ME0328
    Target: PARP
    Summary: PARP抑制剂
      ≥71.43 mg/mL
      insoluble in H2O
  9. Terfenadine
    A8534 Terfenadine
    中文名: 特非那定
    Target: Voltage-gated Potassium (KV) Channels|Histamine H1 Receptors|Inward Rectifier Potassium (Kir) Channels
    Summary: 组胺H1受体拮抗剂
      ≥18 mg/mL
      insoluble in H2O
  10. Veliparib dihydrochloride
    A3958 Veliparib dihydrochloride
    中文名: 维利帕尼二盐酸盐
    Target: PARP
    Summary: PARP-1/PARP-2抑制剂
      ≥31.7 mg/mL
      ≥104 mg/mL

17件产品中的 1-10

页面
每页